Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

March 30, 2021

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2028

Conditions
Colorectal Cancer
Interventions
DIAGNOSTIC_TEST

Blood sample

"In cohort A: Blood sample n°1 (PBMC, plasma, ctDNA) previous colonoscopy. If no cancer lesions: STOP. If cancer lesion detected : Blood sample n°2 (PBMC, plasma, ctDNA) collected 1 month after surgery.~In cohort B: Blood sample n°1 (PBMC, plasma, ctDNA) collected before surgery. Blood sample n°2 (PBMC, plasma, ctDNA) collected 1 month after surgery"

OTHER

Tumor tissue

In each cohort, tumor tissue will be collected from the surgical specimen.

OTHER

stool collection

In cohort B: Stool sample n°1 collected before surgery. Stool sample n°2 collected 1 month after surgery

Trial Locations (3)

Unknown

RECRUITING

CHU de Besançon, Besançon

NOT_YET_RECRUITING

Hôpital Nord-Franche-Comté, Montbéliard

NOT_YET_RECRUITING

Centre Hospitalier Intercommunal de Haute-Saône, Vesoul

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER